All C Suite Event – A Conversation with Dr. Luis Jodar*
*This event is reserved for C Suite Executives of Life Sciences PA member organizations involved in biotechnology or pharmaceutical research and development, drug discovery, medical device development, and contract research organizations involved in preclinical research. If you are unsure of your eligibility, please contact Lois Stephens at [email protected]
Join us Friday, March 5 for Life Sciences PA's All C Suite Event to hear Dr. Luis Jodar discuss his experience as SVP & Chief Medical Officer of Vaccines at Pfizer, medical development, clinical and scientific affairs worldwide and his insight in leading the team who developed the COVID-19 Vaccine.
Event Details:
Where: Virtual program, registration is required for access to the event
When: Friday, March 5, 2021
Time: 8:30am - 10:00am EST
Once registered login details will be sent closer to the event date
*There is no registration fee. The cost for this event is fully underwritten by our generous sponsors.
Dr. Luis Jodar, SVP & Chief Medical Officer, Vaccines, Pfizer
Dr. Luis Jodar is Senior Vice President and Chief Medical Officer, Pfizer Vaccines. In this capacity, he heads Pfizer’s vaccines medical development, clinical and scientific affairs worldwide comprising around 200 MD, PhD vaccinologists.
Dr. Jodar joined Pfizer from Wyeth in 2009. Before joining industry, Dr. Jodar was Deputy Director General at the International Vaccine Institute (IVI) in Seoul, Korea, an organization established by the United Nations, as well as an adjunct professor at Seoul National University. At the IVI, he was responsible for directing the Translational Research Division, which conducts programs of interdisciplinary research, including clinical trials, epidemiological research, studies of the economics of vaccine introduction, and sociobehavioral and policy research on vaccines.
Previously, Dr. Jodar worked at the World Health Organization (WHO) leading the global vaccine research and introduction of meningococcal vaccines, activities related to adverse events allegations and quality, safety and correlates of protection of vaccines.
Dr. Jodar is a neuroimmunologist with doctoral and post-doctoral training in Madrid, Osaka and Nagasaki Universities. He has worked in vaccine-related programs in more than 50 countries, published in the most accredited peer-review journals, and served on a number of advisory groups on vaccines to WHO, the EU, vaccine manufacturers and governments. He teaches at the Institut Pasteur and ADVAC and has a long track-record in launching and coordinating public-private partnerships to accelerate the development and introduction of vaccines of public health importance for developing and middle-income countries. He has also been awarded several honors including the “cross of officer of the order of civil merit” from the King of Spain for his work in developing countries.
THANK YOU TO OUR SPONSORS
MORGAN LEWIS
At Morgan Lewis, we work in collaboration around the world—always ready to respond to the needs of our clients and craft powerful solutions for them. From our offices in strategic hubs of commerce, law, and government across North America, Asia, Europe, and the Middle East, we work with clients ranging from established, global Fortune 100 companies to enterprising startups.
Our team of more than 2,200 lawyers and specialists provides comprehensive corporate, transactional, litigation, and regulatory services in major industries, including energy, financial services, healthcare, life sciences, retail and ecommerce, sports, technology, and transportation. We focus on both immediate and long-term goals with our clients, helping them address and anticipate challenges across vast and rapidly changing landscapes.
We approach every representation with an equal commitment to first understanding, and then efficiently and effectively advancing, the interests of our clients and arriving at the best results. If a client has a question, we’ll immediately find the person in our global network with the answer. If there’s a shift in the legal landscape, we’re on top of it, and our clients will be too.
Founded in 1873, we stand on the shoulders of nearly 150 years of achievement, but we never rest on our reputation.
TUNNELL CONSULTING
Founded in 1962, Tunnell is an employee-owned company that is exclusively focused on Life Sciences companies and healthcare related government agencies. As such, Tunnell supports the mission and objectives of a variety of organizations, including start-ups / emerging companies, established bio/pharmas, CMOs, the U.S. Government and investors. We integrate strategic, technical, process, quality, regulatory, organizational, manufacturing and staffing expertise to design and implement sustainable solutions that meet our clients’ needs. Headquartered in King of Prussia, PA with offices in Cambridge, MA and Bethesda, MD, Tunnell combines deep industry knowledge and scientific credentials that result in measurable results which boost the operating performance of each unique client.
